• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

March 19, 2018
Company Drug/Device Medical Condition Status
XW Laboratories Inc. XW10172 Narcolepsy Phase I trials initiated
Cadent Therapeutics CAD-1883 Neurological (Essential Tremor) and psychiatric disease (Spinocerebellar ataxia) Phase I trials initiated
Arrowhead Pharmaceuticals, Inc. ARO-AAT Alpha-1 liver disease Phase I trials initiated
Voyager Therapeutics VY-AADC Advanced Parkinson’s disease Phase Ib trials initiated
Protalix Biotherapeutics, Inc. OPRX-106 Ulcerative colitis Phase II trials initiated enrolling 24 subjects
Merrimack Pharmaceuticals, Inc. MM-121 Lung cancer Phase II trials initiated expanding from 80 to 100 subjects
Biogen SPINRAZA (nusinersen) Spinal muscular atrophy (SMA) Phase II trials initiated enrolling 25 pre-symptomatic infants six weeks old or younger
MyoKardia Mavacamten Hypertrophic cardiomyopathy (HCM) Phase II trials initiated
AM-Pharma recombinant human Alkaline Phosphatase (recAP) Acute Kidney Injury (AKI) Phase II trials initiated enrolling 301 subjects with sepsis
Eleven Biotherapeutics, Inc. Vicinium Non-muscle invasive bladder cancer (NMIBC) previously treated with bacillus Calmette-Guérin (BCG) Phase III trials initiated
AbbVie Elagolix Uterine fibroids Phase III trials initiated
Merck KEYTRUDA (pembrolizumab) Advanced cervical cancer with disease progression on or after chemotherapy Priority Review granted by the FDA
Cerapedics, Inc. P-15L Transforaminal lumbar interbody fusion (TLIF) surgery for degenerative disk disease IDE Approval granted by the FDA
Proteostasis Therapeutics PTI-428 Cystic fibrosis Breakthrough Designation granted by the FDA

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing